Description
OMEPRAZOLE CAPSULES FOR PHARMACEUTICAL REOACKAGING PROGRAM MOD #3 DECREASES FUNDING BASED ON ACTUAL YIELD
Base award description: OMEPRAZOLE CAPSULES FOR PHARMACEUTICAL REOACKAGING PROGRAM (797-D-9748)
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-07-03+$1,867,239= $1,867,239
- Mod P000012014-08-07+$14,603= $1,881,842
- Mod P000022014-08-12+$628= $1,882,470
- Mod P000032014-09-02-$4,020= $1,878,450
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-07-03 | +$1,867,239 | $1,867,239 | OMEPRAZOLE CAPSULES FOR PHARMACEUTICAL REOACKAGING PROGRAM (797-D-9748) |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-08-07 | +$14,603 | $1,881,842 | OMEPRAZOLE CAPSULES FOR PHARMACEUTICAL REOACKAGING PROGRAM MOD #1 INCREASES FUNDING FOR ADDITIONAL 295 BOTTLES… |
| Mod P00002· FUNDING ONLY ACTION | 2014-08-12 | +$628 | $1,882,470 | OMEPRAZOLE CAPSULES FOR PHARMACEUTICAL REOACKAGING PROGRAM MOD #2 INCREASES FUNDING BASES ON ESTIMATED YIELD |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2014-09-02 | −$4,020 | $1,878,450 | OMEPRAZOLE CAPSULES FOR PHARMACEUTICAL REOACKAGING PROGRAM MOD #3 DECREASES FUNDING BASED ON ACTUAL YIELD |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UW6UVG3T5LX6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79720N0017 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $583,106 | FY2020 |
| 36E79720N0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $845,319 | FY2020 |
| 36E79720N0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $669,466 | FY2020 |
| 36E79720N0007 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $374,423 | FY2020 |
| 36E79720N0006 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $277,856 | FY2020 |
| 36E79720N0002 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $393,081 | FY2020 |
Other recipients under 6505 from DEPT OF VETERANS AFFAIRS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P16J0052 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $71,957 | FY2016 |
| VA797P16J0053 | EXCELLIUM PHARMACEUTICAL INC. | DEPT OF VETERANS AFFAIRS | $69,294 | FY2016 |
| VA797P16J0051 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | DEPT OF VETERANS AFFAIRS | $227,935 | FY2016 |
| VA797P16J0050 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $22,663 | FY2016 |
| VA797P16J0049 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $32,995 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA797P14J0059_3600_VA797P13A0006_3600 · retrieved 2026-09-26.